Multiple Myeloma, drug therapy
- Name
- Multiple Myeloma, drug therapy
- Accession Number
- DBCAT003831
- Description
Not Available
- Drugs
Drug Drug Description Lucatumumab Investigated for use/treatment in leukemia (lymphoid), multiple myeloma, and lymphoma (unspecified). Isatuximab A chimeric monoclonal antibody targeted against surface CD38 glycoproteins for the treatment of multiple myeloma in patients who have failed previous therapies. - Drugs & Drug Targets
Drug Target Type Lucatumumab Tumor necrosis factor receptor superfamily member 5 target Isatuximab ADP-ribosyl cyclase 1 target